AsOf

Recorded or changed on this day 2026-11-08

44,901–44,950 of 46,535 claims, by entity. Everything on 2026-11-08 →

superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly operating income · 270,842,000 United States dollar
Vertex Pharmaceuticals quarterly operating income: 270,842,000 United States dollar, claim clm_37FE3BC729D9 · ended · superseded by clm_4FCE9FD3FD98 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly operating income · 269,960,000 United States dollar
Vertex Pharmaceuticals quarterly operating income: 269,960,000 United States dollar, claim clm_3837B5FA4621 · ended · superseded by clm_63C6CFD02CA4 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · cash and equivalents · 11,110,200,000 United States dollar
Vertex Pharmaceuticals cash and equivalents: 11,110,200,000 United States dollar, claim clm_3876937046B3 · ended · superseded by clm_CEBE7B1AF903 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total equity · 4,435,203,000 United States dollar
Vertex Pharmaceuticals total equity: 4,435,203,000 United States dollar, claim clm_38ED4A3E086C · ended · superseded by clm_19FEE797F4E7 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly net income · 267,427,000 United States dollar
Vertex Pharmaceuticals quarterly net income: 267,427,000 United States dollar, claim clm_391AC2F64417 · ended · superseded by clm_81C047352B0D · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total equity · 238,874,000 United States dollar
Vertex Pharmaceuticals total equity: 238,874,000 United States dollar, claim clm_393679081B64 · ended · superseded by clm_9E65725B61EB · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · cash and equivalents · 583,181,000 United States dollar
Vertex Pharmaceuticals cash and equivalents: 583,181,000 United States dollar, claim clm_393B542CC9D8 · ended · superseded by clm_9BA598811A16 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total assets · 2,896,787,000 United States dollar
Vertex Pharmaceuticals total assets: 2,896,787,000 United States dollar, claim clm_39A46EBA4944 · ended · superseded by clm_218F213EBD5A · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly operating income · -171,985,000 United States dollar
Vertex Pharmaceuticals quarterly operating income: -171,985,000 United States dollar, claim clm_3ADC1054C2B6 · ended · superseded by clm_00535EE0B591 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly operating income · 1,246,900,000 United States dollar
Vertex Pharmaceuticals quarterly operating income: 1,246,900,000 United States dollar, claim clm_3B40C30B5BFE · ended · superseded by clm_60BA65E99F72 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · shares outstanding · 257,091,441 shares
Vertex Pharmaceuticals shares outstanding: 257,091,441 shares, claim clm_3C5FD882584C · ended · superseded by clm_D7E4C28F5ECB · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly operating income · -3,514,700,000 United States dollar
Vertex Pharmaceuticals quarterly operating income: -3,514,700,000 United States dollar, claim clm_3C97D5DB5816 · ended · superseded by clm_8EC7750600BF · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · net income · -556,334,000 United States dollar
Vertex Pharmaceuticals net income: -556,334,000 United States dollar, claim clm_3CC906E153DA · ended · superseded by clm_2BC71558F3C9 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly revenue · 431,608,000 United States dollar
Vertex Pharmaceuticals quarterly revenue: 431,608,000 United States dollar, claim clm_3D46B58FF11A · ended · superseded by clm_882D250549DB · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly revenue · 858,435,000 United States dollar
Vertex Pharmaceuticals quarterly revenue: 858,435,000 United States dollar, claim clm_3E7B3994881E · ended · superseded by clm_CDABAE46C981 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total assets · 6,543,114,000 United States dollar
Vertex Pharmaceuticals total assets: 6,543,114,000 United States dollar, claim clm_3ECBB5B268CD · ended · superseded by clm_0B97F438BFA4 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total equity · 18,546,600,000 United States dollar
Vertex Pharmaceuticals total equity: 18,546,600,000 United States dollar, claim clm_3F0C247C527A · ended · superseded by clm_D1FB9551C69B · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · revenue · 175,504,000 United States dollar
Vertex Pharmaceuticals revenue: 175,504,000 United States dollar, claim clm_3F47912035B4 · ended · superseded by clm_72998EF97E5B · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · cash and equivalents · 4,972,200,000 United States dollar
Vertex Pharmaceuticals cash and equivalents: 4,972,200,000 United States dollar, claim clm_3F4C3A8A99D1 · ended · superseded by clm_2FB43E38D7CC · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total assets · 2,609,641,000 United States dollar
Vertex Pharmaceuticals total assets: 2,609,641,000 United States dollar, claim clm_3FA9F1E3CCFF · ended · superseded by clm_39A46EBA4944 · 1 source (1 primary) · conf 0.95
valid: Two independent sources agree, or a primary source states it: the record asserts this claim, unless it is a post, is marked for review or carries a confidence below 0.5.
Vertex Pharmaceuticals · net income · 3,953,200,000 United States dollar
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · shares outstanding · 252,902,848 shares
Vertex Pharmaceuticals shares outstanding: 252,902,848 shares, claim clm_40905FFA2E58 · ended · superseded by clm_0E283F15F605 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly revenue · 2,690,600,000 United States dollar
Vertex Pharmaceuticals quarterly revenue: 2,690,600,000 United States dollar, claim clm_40945582F02C · ended · superseded by clm_99B3D838F073 · 1 source (1 primary) · conf 0.95
valid: Two independent sources agree, or a primary source states it: the record asserts this claim, unless it is a post, is marked for review or carries a confidence below 0.5.
Vertex Pharmaceuticals · cash and equivalents · 4,979,300,000 United States dollar
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly research and development · 190,939,000 United States dollar
Vertex Pharmaceuticals quarterly research and development: 190,939,000 United States…, claim clm_411488F61069 · ended · superseded by clm_2A57AC8A186B · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · shares outstanding · 242,088,884 shares
Vertex Pharmaceuticals shares outstanding: 242,088,884 shares, claim clm_4142294B3920 · ended · superseded by clm_F2E292BAD47A · 1 source (1 primary) · conf 0.95
valid: Two independent sources agree, or a primary source states it: the record asserts this claim, unless it is a post, is marked for review or carries a confidence below 0.5.
Vertex Pharmaceuticals · shares outstanding · 253,537,674 shares
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · cash and equivalents · 1,223,130,000 United States dollar
Vertex Pharmaceuticals cash and equivalents: 1,223,130,000 United States dollar, claim clm_41E7A07E4BD9 · ended · superseded by clm_751B22F9EDDB · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · cash and equivalents · 379,099,000 United States dollar
Vertex Pharmaceuticals cash and equivalents: 379,099,000 United States dollar, claim clm_4285D9F06BA1 · ended · superseded by clm_95893F39D81D · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total assets · 22,730,200,000 United States dollar
Vertex Pharmaceuticals total assets: 22,730,200,000 United States dollar, claim clm_4295FD965DBB · ended · superseded by clm_E4FE15D6C00A · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total assets · 1,955,488,000 United States dollar
Vertex Pharmaceuticals total assets: 1,955,488,000 United States dollar, claim clm_4369373195D9 · ended · superseded by clm_71D593846901 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly research and development · 200,161,000 United States dollar
Vertex Pharmaceuticals quarterly research and development: 200,161,000 United States…, claim clm_440DD76F9BF9 · ended · superseded by clm_74FB230D7BFA · 1 source (1 primary) · conf 0.95
valid: Two independent sources agree, or a primary source states it: the record asserts this claim, unless it is a post, is marked for review or carries a confidence below 0.5.
Vertex Pharmaceuticals · quarterly net income · 653,600,000 United States dollar
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total assets · 2,582,748,000 United States dollar
Vertex Pharmaceuticals total assets: 2,582,748,000 United States dollar, claim clm_4674F8E819AD · ended · superseded by clm_8F39AD572FD3 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total equity · 786,843,000 United States dollar
Vertex Pharmaceuticals total equity: 786,843,000 United States dollar, claim clm_46A87149904E · ended · superseded by clm_7DA2AEFA0080 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly net income · -174,069,000 United States dollar
Vertex Pharmaceuticals quarterly net income: -174,069,000 United States dollar, claim clm_46C52FB158CE · ended · superseded by clm_2E31B54439BF · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total equity · 1,172,269,000 United States dollar
Vertex Pharmaceuticals total equity: 1,172,269,000 United States dollar, claim clm_46E7801D804E · ended · superseded by clm_81C9DAEE5D23 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly operating income · 1,139,500,000 United States dollar
Vertex Pharmaceuticals quarterly operating income: 1,139,500,000 United States dollar, claim clm_472C99A37BC6 · ended · superseded by clm_3C97D5DB5816 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · shares outstanding · 240,521,809 shares
Vertex Pharmaceuticals shares outstanding: 240,521,809 shares, claim clm_479F66F00F16 · ended · superseded by clm_4142294B3920 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · shares outstanding · 208,087,899 shares
Vertex Pharmaceuticals shares outstanding: 208,087,899 shares, claim clm_47B306C70D65 · ended · superseded by clm_AA7202AF1645 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly revenue · 2,097,500,000 United States dollar
Vertex Pharmaceuticals quarterly revenue: 2,097,500,000 United States dollar, claim clm_47EA232B8F9C · ended · superseded by clm_F084A45C1F3A · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly revenue · 221,700,000 United States dollar
Vertex Pharmaceuticals quarterly revenue: 221,700,000 United States dollar, claim clm_48045D19FF6B · ended · superseded by clm_70C273FE1AD2 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · research and development · 1,754,540,000 United States dollar
Vertex Pharmaceuticals research and development: 1,754,540,000 United States dollar, claim clm_4875DCC74B8B · ended · superseded by clm_4E727A17F6D8 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly operating income · -216,388,000 United States dollar
Vertex Pharmaceuticals quarterly operating income: -216,388,000 United States dollar, claim clm_4AA01F0AE5BB · ended · superseded by clm_F90C0CD0E0F7 · 1 source (1 primary) · conf 0.95
valid: Two independent sources agree, or a primary source states it: the record asserts this claim, unless it is a post, is marked for review or carries a confidence below 0.5.
Vertex Pharmaceuticals · agreement · Alpine Immune Sciences, Inc.
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly net income · 930,500,000 United States dollar
Vertex Pharmaceuticals quarterly net income: 930,500,000 United States dollar, claim clm_4BC06D9A5911 · ended · superseded by clm_CCC1584CC243 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly operating income · 672,241,000 United States dollar
Vertex Pharmaceuticals quarterly operating income: 672,241,000 United States dollar, claim clm_4C3B1A02B828 · ended · superseded by clm_C212C614D9A6 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · cash and equivalents · 424,045,000 United States dollar
Vertex Pharmaceuticals cash and equivalents: 424,045,000 United States dollar, claim clm_4CF2DBBF2865 · ended · superseded by clm_A8C0C28AF1BF · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly research and development · 228,624,000 United States dollar
Vertex Pharmaceuticals quarterly research and development: 228,624,000 United States…, claim clm_4D0F0C1EE546 · ended · superseded by clm_4F43AE81E1E8 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly operating income · 779,000,000 United States dollar
Vertex Pharmaceuticals quarterly operating income: 779,000,000 United States dollar, claim clm_4D9C12DA102E · ended · superseded by clm_641582E9BBA4 · 1 source (1 primary) · conf 0.95

What the statuses mean